No Consistent Association Between COVID-19 Antiviral Treatments, “Rebound” Infections, CDC Analysis Shows

The Hill (12/21, Weixel) reports, “There is no consistent association between COVID-19 antiviral treatments and ‘rebound’ infections, according to a new” CDC analysis. While “early treatment with an antiviral such as Paxlovid or remdesivir prevents hospitalization and death among patients with mild to moderate COVID-19 who are at risk for severe disease,” these antiviral therapies “are underutilized – possibly because of concerns over rebound.” But the “CDC review of existing studies found COVID-19 rebound can happen in patients whether they received antiviral treatments or not.”